AlaninePlacebo EffectAlanine TransaminaseDouble-Blind MethodAlanine RacemaseInterleukin-1betabeta 2-MicroglobulinAlanine DehydrogenaseReceptors, Adrenergic, betaIntegrin beta3Molecular Sequence DataCross-Over StudiesTransforming Growth Factor betaTreatment OutcomeMutagenesis, Site-DirectedAmino Acid SequenceDose-Response Relationship, DrugIntegrin alpha5beta1Integrin beta4Recombinant ProteinsAspartate AminotransferasesBinding SitesIntegrin alpha6beta4Integrin beta ChainsBase Sequencebeta 2-Glycoprotein IKineticsTime FactorsCell LineAmino Acid SubstitutionMutationAmino AcidsIntegrin alpha4beta1Receptors, Adrenergic, beta-2Integrin alpha2beta1Administration, OralCells, CulturedInterleukin-1Models, MolecularIntegrinsAntigens, CD29LiverIntegrin alpha6beta1Drug Therapy, CombinationRNA, MessengerPhosphorylationReceptors, Adrenergic, beta-1Protein ConformationAdrenergic beta-AgonistsSignal TransductionGlycogen Synthase Kinase 3Integrin alpha1beta1Structure-Activity RelationshipSequence Homology, Amino AcidRandomized Controlled Trials as TopicTransfectionEstrogen Receptor betaTransforming Growth Factor beta1PropanolaminesClinical Trials as TopicGlutamineDrug Administration ScheduleAdrenergic beta-2 Receptor AgonistsReceptors, Adrenergic, beta-3Cell AdhesionSerineCloning, MolecularTransaminasesAdrenergic beta-AntagonistsEscherichia coliPeptide FragmentsMacromolecular SubstancesBeta RhythmProtein Structure, SecondaryRecombinant Fusion ProteinsMice, Inbred C57BLGene Expression RegulationAlbuterolDNA Polymerase betaRandom AllocationSubstrate SpecificityProtein SubunitsAntibodies, Monoclonalbeta CateninGlycineDNA PrimersSingle-Blind MethodCricetinaeReceptors, Transforming Growth Factor betaGene ExpressionAnalysis of VarianceMagnetic Resonance SpectroscopyPoint MutationLigandsThreonineCysteineMutagenesisBlotting, WesternSequence AlignmentInsulin